HOME Press Releases Chromatography Resin Market worth 2.46 Billion USD by 2021



Chromatography Resin Market worth 2.46 Billion USD by 2021


The report "Chromatography Resin Market by Type (Natural, Synthetic, Inorganic media), Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Multi-Modal), Application (Pharmaceutical & Biotechnology, Food & Beverage) - Global Forecast to 2021", The market for chromatography resin is projected to grow from USD 1.72 Billion in 2016 to USD 2.46 Billion by 2021, at a CAGR of 7.41% from 2016 to 2021. Factors such as growing demand for therapeutic antibodies, rising R&D in biopharmaceuticals, and increasing use of chromatography as a separation technique in the food & beverage industry are driving the market.

                  Request Sample                  Request Sample

Browse 94 market data tables and 41 figures spread through 145 pages and in-depth TOC on "Chromatography Resin Market by Type (Natural, Synthetic, Inorganic media), Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Multi-Modal), Application (Pharmaceutical & Biotechnology, Food & Beverage) - Global Forecast to 2021"
http://www.marketsandmarkets.com/Market-Reports/chromatography-resins-market-933.html
Early buyers will receive 10% customization on reports.

Ion exchange chromatography is projected to be the fastest-growing segment in the chromatography resin market

The ion exchange segment accounted for the largest share in 2015, in terms of volume, and is projected to grow at a considerable rate during the forecast period. Ion exchange chromatography technique is widely used for biopharmaceutical purification processes. It is used in combination with other techniques, wherein the use of protein A resins is not a commercially preferred option. This has led to the high demand for ion exchange resins in the past decade.

The pharmaceutical & biotechnology segment to account for the largest share of the chromatography resin market

The pharmaceutical & biotechnology segment accounted for the largest market share in 2015, owing to increasing use of monoclonal antibodies in key therapeutic areas, such as oncology, tuberculosis, and other autoimmune diseases. Increasing number of contract manufacturing organizations (CMOs) and contract research organizations (CROs) in the pharmaceutical industry are expected to create new opportunities for chromatography resin manufacturers.

North America is the largest market for chromatography resin

On the basis of region, the chromatography resin market is segmented into the North America, Europe, Asia-Pacific, and RoW. North America is a key market for chromatography resin. The U.S. is the leading market for chromatography resin in the region, followed by Canada. Strong growth in the monoclonal antibody therapeutics market of the region drives the demand for chromatography resins. Modern chromatography techniques are being increasingly used in food analytics and other diagnostic purposes in the U.S. and Canada.

Major players operating in the chromatography resin market are General Electric Company (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Tosoh Corporation (Japan). These companies are adopting strategies such as new product launches, expansions, and contracts & agreements to strengthen their market position, widen their product portfolio, and widen their customer base.

The following companies are the key players in the chromatography resin market:

  • Bio-Rad Laboratories Inc. (U.S.)
  • GE Healthcare (U.S.)
  • Tosoh Corporation (Japan)
  • Merck KGaA (U.S.)
  • Pall Corporation (U.S.)
  • Avantor Performance Materials Inc. (U.S.)
  • Mitsubishi Chemical Corporation (Japan)
  • Purolite Corporation (U.S.)
  • Repligen Corporation (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports